This article, published in the Pediatric Infectious Disease Journal, estimates total vaccine-preventable disease burden and the cost-effectiveness of Hib conjugate vaccine in Indonesia. The study concludes that routine infant Hib vaccination would prevent a large burden of pediatric illness and death in Indonesia. Even without external funding support, Hib vaccine will be a highly cost-effective intervention in either a monovalent or pentavalent presentation based on commonly used benchmarks. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author(s): Gessner BD, Sedyaningsih ER, Griffiths UK, et al.

Published: 2008

Resource types: Peer-reviewed journal

Diseases: Haemophilus influenzae type b (Hib)

Topics: Immunization financing; Disease burden and surveillance; Disease/vaccine specific information

Regions: Asia